Role of Steroids and 10% Hypertonic Sodium Chloride in Adhesiolysis in Post Lumbar Surgery Syndrome Patients
Low Back Pain
About this trial
This is an interventional treatment trial for Low Back Pain focused on measuring Chronic low back pain, Post lumbar laminectomy syndrome, Lower extremity pain, Local anesthetic, Steroid, Percutaneous lumbar adhesiolysis
Eligibility Criteria
Inclusion Criteria:
Inclusion criteria:
- History of lumbar surgery of at least 6 months duration in the past
- Patients over the age of 18 years
- Patients with a history of chronic function-limiting low back pain with or without lower extremity pain of at least 6 months duration (post-surgery)
- Patients who are competent to understand the study protocol and provide voluntary, written informed consent and participate in outcome measurements.
Exclusion criteria:
- Facet joints, uncontrollable as sole pain generators
- Unstable or heavy opioid use (400 mg of morphine equivalents daily)
- Uncontrolled psychiatric disorders
- Uncontrolled medical illness
- Any conditions that could interfere with the interpretation of the outcome assessments
- Pregnant or lactating women
- Patients with a history or potential for adverse reaction(s) to local anesthetic, steroids, or hypertonic sodium chloride solution.
Sites / Locations
- Pain Management Center of Paducah
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Celestone
sodium chloride solution
sodium choride solution
Double substitutes
Group I will receive adhesiolysis, local anesthetic, 10% sodium chloride solution, and non-particulate Celestone
Group II will receive adhesiolysis, local anesthetic, 10% sodium chloride solution, and 0.9% sodium chloride solution to substitute for non-particulate Celestone
Group III will receive adhesiolysis, local anesthetic, normal sodium chloride solution instead of 10% hypertonic sodium chloride solution and non-particulate Celestone;
Group IV will receive adhesiolysis, local anesthetic, and 0.9% sodium chloride solution to substitute for the 10% hypertonic sodium chloride, and 0.9% sodium chloride solution to substitute for non-particulate Celestone